about
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple SclerosisNew Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised HostsA snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection
P50
description
researcher
@en
wetenschapper
@nl
name
Valentina Svicher
@en
Valentina Svicher
@nl
type
label
Valentina Svicher
@en
Valentina Svicher
@nl
prefLabel
Valentina Svicher
@en
Valentina Svicher
@nl
P31
P496
0000-0002-2377-504X